Basic Information
MOFECON 500 FILM-COATED TABLETS 500 MG
TABLET, FILM COATED
Regulatory Information
SIN16010P
September 18, 2020
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XL04AA06
Company Information
Active Ingredients
Strength: 500 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** Mofecon should not be given to: - Patients with hypersensitivity to mycophenolate mofetil, mycophenolic acid or to any of the excipients shown above – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. - Women of childbearing potential who are not using highly effective contraception. - Women of childbearing potential without providing a pregnancy test result to rule out unintended use in pregnancy. - During pregnancy due to its mutagenic and teratogenic potential. - Women who are breastfeeding.
Indication Information
**INDICATIONS** Mofecon is indicated for: - prophylaxis of acute organ rejection and treatment of refractory organ rejection in patients receiving allogeneic renal transplants. - prophylaxis of acute organ rejection and increased graft and patient survival in patients receiving allogeneic cardiac transplants. - prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants. Mofecon should be used concomitantly with cyclosporin and corticosteroids.